BIOXCEL THERAPEUTICS INC (BTAI) Institutional Buying Activity
Institutional investors tracked by InsiderSet increased exposure to BIOXCEL THERAPEUTICS INC (BTAI) during the quarter ended June 30, 2025 through a combination of new purchases and expanded existing positions disclosed in SEC Form 13F filings.
The largest institutional buyer of BTAI during the latest reporting period was Oaktree Capital Management, which increased its reported BTAI position by approximately $436,551 based on quarter-end filing values. Several additional hedge funds and long-term asset managers also reported meaningful increases in BTAI exposure during the quarter.
Institutional buying activity can provide insight into investor conviction, sector allocation trends, and smart money positioning toward BIOXCEL THERAPEUTICS INC (BTAI). InsiderSet tracks quarterly accumulation trends, new institutional positions, ownership increases, and estimated performance of newly disclosed holdings using SEC filing data and recent market prices.
The investors highlighted on this page collectively added approximately $436,551 in reported BTAI exposure during the latest filing period, reflecting continued institutional interest in BIOXCEL THERAPEUTICS INC's growth initiatives and strategic positioning.
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q2 2025 | Oaktree Capital Management | Buy | 241,188 | 241,188 | $436,551 |
Frequently asked questions about BTAI activity
Which institutional owners are buying BTAI?
Institutional owners buying BTAI include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in BTAI activity?
"Buy" means an investor increased their reported position in BTAI compared to the prior reporting period. This reflects growing exposure to BIOXCEL THERAPEUTICS INC (BTAI) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in BTAI increasing?
Institutional interest in BTAI can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.